Oncaspar solution for injection

Medicines | 19/11/2013

The company responsible for distribution, sigma-tau ArzneimittelGmbH, 40212 Düsseldorf, Germany, informed its supplied customers on November 15, 2013, that individual containers of the above-mentioned batches may have fine cracks that may lead to leakage (presumed incidence: 1/5,000), which may pose a risk of microbial contamination. Replacements will likely be available in approximately two weeks. Until then, if an alternative treatment is not available, treatment with affected batches should only be carried out in individual cases under special precautions (see safety letter from sigma-tau).

Name of the medicinal product Oncaspar Injektionslösung
Durchstechflasche mit 5ml Injektionslösung
Pegaspargase (3750 I.E. L-Asparaginase)
Marketing authorisation number(s) 30204.00.00 (Deutschland)
Marketing authorisation holder sigma-tau Rare Diseases SA
Rua dos Ferreiros, 260, 9000-082 Funchal, Portugal
Batch number(s) ON3007D1, ON3007X2, ON3008D1, ON3008X2, ON3009X2, ON3010D1, ON3010X2
Classification of the recall1
BASG reference number INS-640.001-0945
Email

Further inquiry note